REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance
Author:
Xiaoling Wang,Youcai Huang,Mingwei Sun,Shuyi Cai,Xiaoyu Hu,Yi Zheng,Shumin Fang,Sumei Li,Yanyang Tu,Huanwen Tang
Publication:
Translational Oncology
© 2026 The Authors. Published by Elsevier Inc.